Malaysia’s National Pharmaceutical Regulatory Agency (NPRA) is preparing to trial new timelines for variation applications to “provide greater clarity and more effective monitoring.” NPRA published ...
As part of an initiative to improve regulatory reviews, Health Canada aims to provide a new formal process for device firms seeking early advice. The regulatory authority is calling on device ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results